Celldex Therapeutics CLDX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$78.69M-46.3% | -$81.32M-72.7% | -$67.04M-59.2% | -$56.6M-57.9% | -$53.8M-64.0% | ||
| $854K-1.5% | $816K-0.4% | $824K+4.8% | $873K+9.5% | $867K+11.9% | ||
| $8.52M-8.5% | $8.91M-8.9% | $8.8M-8.5% | $9.19M+20.3% | $9.32M+29.4% | ||
| -$65.59M-20.6% | -$63.94M-96.9% | -$48.63M+12.1% | -$44.01M-50.0% | -$54.37M-33.8% | ||
| $1.64M+518% | $1.28M+69.4% | $440K-19.3% | $728K+166% | $265K-23.0% | ||
| $72.12M+67.9% | $55.43M— | $60.85M— | $49.85M+207% | $42.95M+114% | ||
| $327K+61.9% | $1.35M+249% | $774K-37.5% | $63K-98.3% | $202K-100.0% | ||
| $6.86M+161% | —— | $12.99M— | —— | -$11.22M-114% | ||
| -$67.23M-23.0% | -$65.22M-96.3% | -$49.07M+12.2% | -$44.73M-51.1% | -$54.64M-33.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Celldex Therapeutics generate?
- Celldex Therapeutics (CLDX) generated -$222.2M in operating cash flow over the trailing twelve months.
- What is Celldex Therapeutics's free cash flow?
- After $4.1M of capital expenditures, Celldex Therapeutics's free cash flow was -$226.2M over the trailing twelve months, down 30.5% year over year.
- Where does Celldex Therapeutics's cash flow data come from?
- Every line is extracted from Celldex Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
